Recursion Pharmaceuticals, Inc. (RXRX) Capital expenditures 2019–2025
Recursion Pharmaceuticals, Inc. (RXRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6.5MFY2025 · since FY2019: $3.9M → $6.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.5M | -52.8% |
| FY2024 | $13.7M | +14.6% |
| FY2023 | $12.0M | -67.7% |
| FY2022 | $37.1M | -6.9% |
| FY2021 | $39.8M | +582.5% |
| FY2020 | $5.8M | +49.1% |
| FY2019 | $3.9M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice